CINTAS CORP
CTASAbout the company
Cintas Corporation provides corporate identity uniforms and other garments in the United States, Canada, and Latin America. It operates through Uniform Rental and Facility Services, First Aid and Safety Services, and All Other segments. The company offers rental and servicing of uniforms and other garments, including flame resistant clothing, mats, mops and shop towels, and other ancillary items.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
4 / 6
NEUTRAL / FAIL
Median fair value
$67.18
-66.0% vs price
Models with upside
0 / 16
Positive margin of safety
Strongest signal
7 of 8 pass — Piotroski objects
Key risk
No clean pass — all 12 investors flag at least one valuation criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | Munger Quality Focus | Sleep Scale Economies Shared | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Akre Three-Legged Stool | Pabrai Dhandho Framework | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Lynch GARP | Graham Defensive Value | Buffett Quality Compounder | O'Shaughnessy Systematic Factor Composite | Schloss Asset-Value Discipline | Neff Low-P/E Total Return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | BUY | NEUTRAL | FAIL | NEUTRAL | FAIL | NEUTRAL | PASS | PASS | FAIL · Rank #954 (Top 29.7%) | FAIL | FAIL | PASS | FAIL | NEUTRAL | FAIL |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | -153.9% | N/A | N/A | N/A | -108.4% | -194.3% | -116.9% | N/A | N/A | -345.8% | N/A | -482.8% | -255.3% | N/A | N/A | N/A |
| Data As Of | 10-K (2026-08-19) | 10-K (2026-08-19) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-18) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) |
Where It Passes
- Efficiency88% pass✓ 9✗ 2▾
7 of 8 pass — Piotroski objects
Return on Invested Capital26.2%✓Munger> 15%ROIC (5-year)5/5 years above 12% (latest 26.2%)✓SleepROIC > 12% in a majority of yearsROIC (high and growing)10/18 years ROIC > 15% (latest: 26.2%)✓AkreROIC > 15% for 3+ yearsReinvestment Rate x ROIC17.4% (RR=66% x ROIC=26.2%)✓AkreReinvestment Rate * ROIC > 10%Current Assets / Current Liabilities2.09✓Dreman> 1.5Current Ratio Change YoY2.09 -> 2.09✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.05x -> 1.05x✗PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)74.2%✓Greenblatt> 25%Current Ratio2.09✓Graham>= 2.0ROIC (3-5 yr avg)24.7%✓Buffett> 10%ROIC - WACC+14.7%✓BuffettPositive (WACC = 10%) - Debt & Leverage55% pass✓ 8✗ 6▾
6 of 11 pass — Munger, Akre, Lynch +2 more object
Debt Levels0.52✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Total Debt / Shareholders' Equity0.52✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓Dreman< 0.8✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDAIC=23.2x, D/EBITDA=0.8x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.52✓Ackman<= 1.0Current Assets / Current Liabilities2.09✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)LT Debt / Total Assets Change24.68% -> 24.68%✓PiotroskiDecreased YoYTotal Debt / Equity0.52✗Lynch< 0.33Cash - Long-term Debt$-2.2B✗LynchPositive preferredLT Debt vs Net Current AssetsLT Debt $2.4B vs NCA $1.8B✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.52, IC: 23.2x✗BuffettD/E < 0.5 AND Interest Coverage > 5x
Where It Falls Short
- Valuation0% pass✓ 1✗ 25▾
No clean pass — all 12 investors flag at least one valuation criterion
Valuation ReasonablenessP/E=45.3x, OE Yield=2.4%✗MungerP/E < 25 or Owner Earnings Yield > 5%Price / EPS45.0x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✗Dreman< 12xPrice vs. Trailing Low117% of trailing low ($169.14)✓Templeton<= 120% of trailing low (post-2025 live window only)Price / Book Value per Share17.0x✗Templeton< 1.5x✗Dreman< 1.2x✗SchlossP/B <= 0.80x (app cutoff)P/B or P/E vs. Historical AverageP/E=45.0x, P/B=17.0x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-214.2% (IV=$62.95 vs Price=$197.82)✗Marks>= 20% below intrinsic valueP/E or FCF YieldP/E=45.0x, FCF Yield=2.2%✗PabraiP/E < 15 or FCF Yield > 10%Price / FCF per Share45.4x✗Ackman<= 25Price / (CFO / Shares)36.8x✗Dreman< 8xEBIT / Enterprise Value2.9%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=2.9%, ROC=74.2%✗GreenblattBoth EY > 10% and ROC > 25%P/E / EPS Growth Rate✗Lynch< 1.0 (ideally < 0.5)Price / 3-yr avg EPS47.1x✗Graham<= 15xPrice-to-Book Ratio17.0x✗Graham<= 1.5xP/E x P/B802.10✗Graham<= 22.5Revenue / market capitalization+0.1309; #4026/5203 (top 77.4%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+2.29%; #2457/6251 (top 39.3%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+2.22%; #2142/4487 (top 47.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+16.91%; #1772/6203 (top 28.6%)✗OshaughnessyTop 10% of eligible cross-sectionPrice / Tangible Book Value per Share135.08x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS44.9x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge) - Valuation models0% pass✗ 7▾
CTAS overvalued: all 7 models price fair value below $197.74 (median $67.18)
Munger fair value$77.88✗Munger-153.9% margin vs $197.74Akre fair value$94.89✗Akre-108.4% margin vs $197.74Pabrai fair value$67.18✗Pabrai-194.3% margin vs $197.74Ackman fair value$91.16✗Ackman-116.9% margin vs $197.74Greenblatt fair value$44.36✗Greenblatt-345.8% margin vs $197.74Graham fair value$33.93✗Graham-482.8% margin vs $197.74Buffett fair value$55.65✗Buffett-255.3% margin vs $197.74 - Growth13% pass✓ 3✗ 10▾
7 of 8 flag CTAS's growth — Sleep, Templeton, Ackman +4 more
Revenue growth vs. gross and operating margin trendgross margin 48.8% -> 50.0%, operating margin 21.6% -> 22.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR7.8%✓SleepCAGR > 7%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency31/31 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth7.7%✓Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedP/E / EPS Growth Rate✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 0.0% vs Rev: 0.0%✗LynchInventory growth < Revenue growthEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growth3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability27% pass✓ 14✗ 16▾
11 of 15 flag CTAS's profitability — Sleep, Templeton, Marks +8 more
Revenue growth vs. gross and operating margin trendgross margin 48.8% -> 50.0%, operating margin 21.6% -> 22.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend21.6% (2023) -> 22.8% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value-214.2% (IV=$62.95 vs Price=$197.82)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency31/31 years positive✓MarksPositive net income in >= 7 of last 10 yearsReturn on Equity37.9% (3-yr avg)✓AkreROE > 20% (3-year avg)Margin of SafetyP/E=45.0x, P/B=17.0x✗PabraiP/B < 1.5 or P/E < 15Operating Income / Revenue22.8%✓Ackman>= 15%Net Income / Shareholders Equity38.7%✓Ackman>= 15%Pre-Tax Income / Revenue21.9%✓Dreman>= 8%Net Income / Shareholders' Equity38.7%✓Dreman> 12%Net Income / Total Assets18.45%✓PiotroskiROA > 0ROA Change YoY18.45% -> 18.45% (delta: +0.00%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=22.04%, ROA=18.45%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY50.0% -> 50.0%✗PiotroskiImproved YoYEBIT / Enterprise Value2.9%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=2.9%, ROC=74.2%✗GreenblattBoth EY > 10% and ROC > 25%3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE38.7%✓Lynch> 15%Positive EPS (10 years)23/32 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)31/32 years positive✗BuffettPositive every year for 10+ yearsROE (5-yr avg)37.2%✓Buffett> 15% (5-yr avg)Operating Margin (10-yr trend)22.8% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$1.9B✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdNet income / market capitalization+2.29%; #2457/6251 (top 39.3%)✗OshaughnessyTop 10% of eligible cross-sectionPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Verdicts42% pass✓ 5✗ 7▾
Split decision: 6 FAIL · 4 PASS · 4 NEUTRAL · 1 BUY
Overall verdict✓MungerPASS (2/4)✓SleepBUY (5/6)•TempletonNEUTRAL (5/8)✗MarksFAIL (3/5)•AkreNEUTRAL (4/6)✗PabraiFAIL (1/3)•AckmanNEUTRAL (6/9)✓DremanPASS (5/11)✓PiotroskiPASS (F-Score 5)✗GreenblattRank #954✗LynchFAIL (1/7)✗GrahamFAIL (3/9)✓BuffettPASS (5/9)✗OshaughnessyFAIL (Rank #726/953 (Top 76.2%))•SchlossNEUTRAL (4/7)✗NeffFAIL (3/6) - Cash Flow50% pass✓ 6✗ 6▾
5 of 10 pass — Pabrai, Ackman, Dreman +2 more object
Positive Operating Cash Flow frequency23/23 years positive✓SleepPositive OCF in >= 70% of available yearsFCF Positive18/18 years FCF positive✓MarksPositive FCF in majority of recent yearsP/E or FCF YieldP/E=45.0x, FCF Yield=2.2%✗PabraiP/E < 15 or FCF Yield > 10%(OCF - CapEx) / Market Cap2.2%✗Ackman>= 4%Price / FCF per Share45.4x✗Ackman<= 25Price / (CFO / Shares)36.8x✗Dreman< 8xOperating Cash Flow$2.2B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=22.04%, ROA=18.45%✓PiotroskiCFO/Assets > ROAFCF Positive and Growing$1.8B✗LynchPositive and growingFree Cash Flow Proxy$1.9B✓BuffettPositive and growing(Operating cash flow - capex) / market capitalization+2.22%; #2142/4487 (top 47.7%)✗OshaughnessyTop 10% of eligible cross-sectionOperating Cash Flow - Capital Expenditures$1.8B✓Neff> $0 (app proxy for a strong fundamental case)
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Retired 0.5% of shares last year, 1.0% over two.
- Buybacks
- $934.8M
- Dividends
- $611.6M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Market Cap | $79.0B | $15.0Best. | $11.0Best. | $9.6Best. | $7.9Best. |
| Revenue | $10.3B↑8% | $9.6B↑9% | $8.8B↑12% | $7.9B↑10% | $7.1B |
| Operating Income | $2.4B↑14% | $2.1B↑15% | $1.8B↑14% | $1.6B↑15% | $1.4B |
| Net Income | $1.8B↑15% | $1.6B↑17% | $1.3B↑9% | $1.2B↑11% | $1.1B |
| EPS (Diluted) | $4.40↓71% | $15.15↑17% | $12.99↑12% | $11.65↑14% | $10.24 |
| Gross Margin | 50.0%↑2% | 48.8%↑3% | 47.3%↑2% | 46.2%↓1% | 46.6% |
| Operating Margin | 22.8%↑6% | 21.6%↑5% | 20.4%↑1% | 20.2%↑4% | 19.5% |
| ROE | 38.7%↑6% | 36.4%↑4% | 34.9%↓7% | 37.4%↑24% | 30.1% |
| Total Debt | $2.4B↓2% | $2.5B | $2.5B↓11% | $2.8B↑10% | $2.5B |
| Shareholders' Equity | $4.7B↑9% | $4.3B↑12% | $3.9B↑17% | $3.3B↓10% | $3.7B |
| Current Ratio | 2.09↑20% | 1.74↓27% | 2.39↑30% | 1.84↑25% | 1.47 |
| Debt / Equity | 0.52↓10% | 0.57↓11% | 0.64↓24% | 0.85↑23% | 0.69 |
| Operating Cash Flow | $2.2B↑5% | $2.1B↑30% | $1.6B↑3% | $1.5B↑13% | $1.4B |
| Free Cash Flow | $1.8B↑6% | $1.7B↑32% | $1.3B↓3% | $1.3B↑7% | $1.2B |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
CTAS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| Amer Sports, Inc.AS | $15.2B | $27.24 | $6.6B | $427.4M | 7.4% | 0.14 | 10.7% | 1.50 | 2/9 | 3/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| DECKERS OUTDOOR CORPDECK | $10.8B | $77.68 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 3/3 | F-Score 7 | 5/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| Gildan Activewear Inc.GIL | $7.9B | $42.62 | $3.6B | $398.9M | 11.2% | 1.21 | 17.1% | 2.11 | 3/9 | 5/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| LEVI STRAUSS & COLEVI | $7.6B | $19.75 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |
| Crocs, Inc.CROX | $6.3B | $126.14 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |